Marshall Wace
NRXP icon

Marshall Wace’s NRX Pharmaceuticals NRXP Stock Holding History

Marshall Wace’s Portfolio NRXP Stock Details NRXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.91M Buy
995,172
+800,592
+411% +$2.84M ﹤0.01% 1640
2026
Q2 		$796K Buy
+194,580
New +$643K ﹤0.01% 2313
2025
Q4 		– Sell
-189,136
Closed -$624K – 3313
2025
Q3 		$624K Buy
189,136
+155,752
+467% +$446K ﹤0.01% 2144
2025
Q2 		$109K Sell
33,384
-55,702
-63% -$140K ﹤0.01% 2532
2025
Q1 		$183K Buy
+89,086
New +$251K ﹤0.01% 2425
2022
Q1 		– Sell
-250
Closed -$12K – 3799
2021
Q4 		$12K Buy
+250
New +$18K ﹤0.01% 3741

Other funds holding NRXP

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
AdvisorShares Investments
AdvisorShares Investments Bethesda, Maryland $796M AUM 17.24% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $77B AUM 19.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Prime Capital Investment Advisors
Prime Capital Investment Advisors Overland Park, Kansas $10.2B AUM 17.74% 1-Year Est. Return
Bleakley Financial Group
Bleakley Financial Group Fairfield, New Jersey $8.8B AUM 22.37% 1-Year Est. Return

Marshall Wace's NRXP Position: Q3 2026 in Review

Marshall Wace increased its NRX Pharmaceuticals (NRXP) stake by 411% in Q3 2026, buying an estimated $2.84M and bringing the position to 995,172 shares worth $2.91M. The position accounts for ﹤0.01% of the portfolio, ranked #1640.

Marshall Wace first reported a position in NRXP in Q4 2021 and has held it in 6 quarters since. 33 funds tracked by Wall St. Rank hold NRXP as of Q3 2026.

  • Marshall Wace held 995,172 shares of NRX Pharmaceuticals worth $2.91M as of Q3 2026.
  • Marshall Wace bought 800,592 NRX Pharmaceuticals shares in Q3 2026, an estimated $2.84M.
  • NRX Pharmaceuticals made up ﹤0.01% of Marshall Wace's portfolio in Q3 2026, its #1640 holding.
  • Marshall Wace first reported a position in NRX Pharmaceuticals in Q4 2021 and has held it in 6 quarters since.
  • 33 funds tracked by Wall St. Rank held NRX Pharmaceuticals as of Q3 2026.

Based on Marshall Wace's 13F filing for Q3 2026, filed 13 Nov 2026.